NCT01744470 - Efficacy and Safety Study of a 4-Month Post-Renal Transplant Dose Reduction of Tacrolimus(ADEQUATE) | Biotech Hunter

Enrollment

286

Participants

Timeline

Start Date

May 31, 2012

Primary Completion Date

March 31, 2015

Study Completion Date

March 31, 2015

Conditions

De Novo Transplant Disease

Interventions

DRUG

Tacrolimus targeted half-dose

DRUG

Tacrolimus targeted plain dose

Trial Locations (16)

HEGP, Paris

Hôpital Bois-Guillaume, Bois-Guillaume

Hôpital Sud, Amiens

CHU de Angers, Angers

Hôpital Cavale Blanche, Brest

CHU de Caen, Caen

Hôpital Gabriel Montpied, Clermont-Ferrand

Hôpital Bicêtre, Le Kremlin-Bicêtre

Hôpital Dupuytren, Limoges

Hôpital Archet II, Nice

Hôpital Necker, Paris

Hôpital Maison Blanche, Reims

Hôpital Pontchaillou, Rennes

Hôpital Civil, Strasbourg

CHU de Toulouse, Toulouse

CHRU de Tours, Tours